Resources
We are indebted to the International Doctors for Healthier Drug Policies for our Resources. We will be adding to them over time.
Co-morbid substance use and mental disorders in Europe: A review of the data
This paper reviews information on the co-morbidity of mental disorders among individuals with psychoactive drug or alcohol use problems.
Women who use drugs, harm reduction and HIV
This brief brings attention to policies, laws and practices that undermine the rights of women who use drugs, and to promote the realisation of their human rights in terms of an effective harm reduction response to HIV.
Rise in LSD use among regular psychostimulant users: Why the increase and is it a cause for concern?
Although currently, LSD is not as popular and wide spread as its peak in the 1960s it is still considered one of the main illicit drugs used in Australia, where is more prevalent than in the US and UK.
Drug policy organisations in Europe
This paper sets out to explore the civil society organisations that engage in drug policy advocacy in Europe. The most of the organisations are working in the area of practice development, with 26 % advocating use reduction and 39 % harm reduction approaches.
Policy paper on preventing risks and reducing harm linked to the use of psychoactive substances
This paper provides an overview and conceptualisation of policy areas and goals under which risk and harm reduction measures are presently implemented in Europe.
Mistreatment of drug users and in Cambodia’s drug detention centers
Human Rights Watch calls on Cambodia’s to permanently close its drug detention centers that at any point in time, collectively hold around 1,000 men, women, and children.
Compulsory drug detention in East and Southeast Asia: Evolving government, UN and donor responses
More than 235,000 people are detained in over 1000 compulsory drug detention centers in East and South East Asia. As a result of the human right violations associated with this centres, an increasing number of United Nations agencies, human rights experts, and others have called for their closure, marking a significant shift from past engagement with drug detention.
Frankfurt principles on drug law enforcement
This principles, approved at the International Conference on Drug Policy and Policing recognise that public safety incorporates crime prevention, law enforcement and public health.
Accelerating HIV treatment
The HIV treatment crisis in the in WHO Eastern Mediterranean and UNAIDS Middle East and North Africa is reversible. Implementing the recommended actions soonest will enable the Region to achieve universal coverage for HIV treatment.
Drug policies from a public health and human rights perspective
The main topics discussed in the dialogue between government officials and members of civil society at the Inter-American Drug Abuse Control Commission were drug consumption from a public health perspective, human rights and drug laws.
Advancing service integration in opioid treatment progams for the care and treatment of hepatitis C infection
Approximately 200 million people globally are infected with the hepatitis C virus. Integrating hepatitis care services and treatment foster access to care for patients with hepatitis C infection.
The UNGASS on drugs in 2016: A milestone for HIV/AIDS NGOS policy in Africa
Data are limited, but the evidence tells us that injecting drug use is a growing problem in Africa. This threatens to quickly undermine the achievements on the continent.
Mortality after prison release: Opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009
Among former prisoners, a high rate of death has been documented in the early postrelease period, particularly from drug-related and opioid overdose causes.
Recommendations for testing, managing, and treating hepatitis C
The landscape of treatment for hepatitis C virus (HCV) infection has evolved substantially since the introduction of highly effective HCV protease inhibitor therapies in 2011.
Patterns, determinants and barriers of health and social service utilization among young urban crack users in Brazil
This study examined profiles and determinants of social and health service utilization, and unmet service needs, in a two-city sample of young, marginalised crack users in Brazil.
Clinical update from SMMGP/ Nov 2013
This clinical update from Substance Misuse Management in General Practice highlights topics as the experiences on hepatitis C and heroin overdose management.
EASL clinical practice guidelines: Management of hepatitis C virus infection
These EASL Clinical Practice Guidelines assist physicians and other healthcare providers in the clinical decision-making process by describing the optimal management of patients with acute and chronic HCV infections.
The harms of drug use: Criminalisation, misinformation, and stigma
Legislation and media representation and coverage rarely reflect the empirical qualitative or quantitative harm caused by drug use, topics that this publication explores.
1st Scottish Harm reduction cafe report
This report offers the experience of a harm reduction cafe held in Glasgow in November 2013 intends to support anyone wanting to host a harm reduction cafe in their local area.
Injecting drug use among under-18s
There are numerous limitations to existing data that require attention, including under-representation of under-18s in HIV bio-behavioural surveillance and a lack of appropriate age disaggregation.
European initiative on hepatitis C and drug use policy meeting
The goal and purpose of the meeting was to start the process of open formal discussions regarding the development of a European HCV strategic plan and national HCV policies that specifically address the needs of people who use drugs. Read some of the presentations here.
Exploring methamphetamine trends in Europe
Historically, the use of methamphetamine has been confined largely to the Czech Republic and Slovakia; however, recent signs of the spread of methamphetamine linked to different European countries have sparked further investigation of this topic.
The human rights case for drug reform
The Human Rights Watch 2014 World Report highlights that "drug criminalization destroys lives, feeds Abuses, and subverts the rule of law".
Report from the high-level panel on HIV, drug policy and public health in Africa
International Drug Policy Consortium (IDPC), and the United Nations Office on Drugs and Crime (UNODC) hosted this High Level Panel for around 50 participants including policy makers, journalists and programme managers at the 17th International Conference on AIDS and STIs in Africa (ICASA).
The HIV epidemic among injecting drug users in Greece during the economic crisis
This briefing paper addresses the mechanisms implemented to tackle the increasing HIV rates among injecting drug users in Greece.
IDHDP presentation slides - English, French and Russian
Introduction slides on IDHDP available in English, French and Russian
Latin America and the drug issue: Searching for a change
Norwegian Peace Building Resource Center analyses the current global situation of the drug question and highlights the limitations of the so-called “war on drugs”. It specifically reflects on the particularities of the anti-narcotics crusade in Latin America by showing its poor results in terms of coping with the drug phenomenon.
Women who use drugs, harm reduction and HIV
This issue brief about HIV, harm reduction and the sexual and reproductive health and rights of women who use drugs is part of a series of brie"ng papers, commissioned by the Global Coalition on Women and AIDS (GCWA). It focuses on "the gendered nature of elevated risk" and gives recommendations.
Peace, Drug Policy, and an Inclusive Society
Eleven Ways Colombian and FARC Negotiators can Reform Drug Policy and Build a Lasting Peace: recommendations written by WOLA outline 11 elements of a more effective and humane approach to drug policy.